Liver
-
Scientific Literature
Liver Disease in Patients With Transfusion-Dependent β-Thalassemia: The Emerging Role of Metabolism Dysfunction-Associated Steatotic Liver Disease
In this Editorial, we highlight the possible role that metabolism dysfunction-associated steatotic liver disease (MASLD) may play in the future, regarding liver disease in patients with transfusion-dependent β-thalassemia (TDBT). MASLD…
Read More » -
Scientific Literature
Splenectomy Significantly Associated with Thrombosis but Not with Pulmonary Hypertension in Patients with Transfusion-Dependent Thalassemia: A Meta-analysis of Observational Studies
Introduction: Thromboembolism (TE) and pulmonary hypertension (PH) constitute frequently occurring complications in patients with transfusion-dependent thalassemia and have been associated with splenectomy in different studies. Nevertheless, the size of the…
Read More » -
Scientific Literature
Hepatocellular Carcinoma in Transfusion Dependent Thalassemia Patients: A Review from a Clinical Perspective
Survival in patients with transfusion-dependent thalassemias (TDT) has increased, and complications such as hepatocellular carcinoma (HCC) are emerging. Risk factors include viral infection, mainly hepatitis C virus (HCV), iron overload,…
Read More » -
News
TIF Signs Agreement With Resonance Health To Deploy FerriSmart®
FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under the Letter of Agreement, TIF will engage with National Thalassaemia…
Read More » -
Scientific Literature
Phylogenetic Analysis in the Clinical Risk Management of an Outbreak of Hepatitis C Virus Infection Among Transfused Thalassaemia Patients in Italy
Occurrence of hepatitis C virus (HCV) infection is reduced by effective risk management procedures, but patient-to-patient transmission continues to be reported in healthcare settings. To report the use of phylogenetic analysis in the…
Read More » -
News
World Hepatitis Day 2021: Hep Can’t Wait!
July 28 marks World Hepatitis Day 2021. World Hepatitis Day (WHD) is observed every year on 28 July to raise awareness of viral hepatitis, an inflammation of the liver that…
Read More » -
News
TIF Has Joined the EASL Patient Organisations Community
TIF is constantly fortifying synergies with influential patient organisations for the benefit of individuals with thalassaemia and other Haemoglobin Disorders. Therefore, we are excited to announce that the Federation has recently joined one…
Read More » -
Education
eThalED COURSE: Liver Disease & Thalassaemia by Prof John Koskinas
TIF’s 3rd webinar for Medical Specialists on ”Liver Disease & Thalassaemia”, organised in the context of our eThalED Course. Prof. Geoffrey Dusheiko, Emeritus Professor of Medicine & Consultant Hepatologist at…
Read More » -
News
”Liver Disease & Thalassaemia”: En route to the 3rd TIF Webinar for Medical Specialists
Tune in for TIF’s upcoming webinar on ”Liver Disease & Thalassaemia” for Medical Specialists, organised in the context of our eThalED Course on Friday, 31 July, EEST 15:00-16:00. Prof. Geoffrey Dusheiko, Emeritus…
Read More » -
Scientific Literature
Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
With the continuing progress in managing patients with thalassemia, especially in the setting of iron overload and iron chelation, the life span of these patients is increasing, while concomitantly increasing…
Read More »